Endothelin-1 as an Autocrine/Paracrine Apoptosis Survival Factor for Endothelial Cells

Author:

Shichiri Masayoshi1,Kato Hiroki1,Marumo Fumiaki1,Hirata Yukio1

Affiliation:

1. From the Endocrine-Hypertension Division, Second Department of Internal Medicine, Tokyo Medical and Dental University (Japan).

Abstract

Abstract Endothelin-1 (ET-1), an endothelium-derived vasoactive peptide, functions as a potent vasoconstrictor as well as mitogen. We show here a novel role for ET-1 as an apoptosis survival factor for cultured rat endothelial cells. When we rendered endothelial cells obtained from rat aorta quiescent by serum starvation, significant portions of cultured cells underwent apoptotic death as demonstrated by nucleosomal laddering on agarose gel electrophoresis, flow cytometry analysis with FACS, and the TdT-mediated dUTP biotin nick-end labeling (TUNEL) method. ET-1 dose-dependently (10 −12 to 10 −6 mol/L) suppressed the apoptosis induced by serum starvation. The ET B receptor antagonist (BQ788; 10 −6 mol/L) and ET A/B receptor antagonists (PD142893 and PD145065; 10 −6 mol/L), but not the ET A receptor antagonist (BQ123; 10 −6 mol/L), blocked the apoptosis protective effect of 10 −7 mol/L ET-1. Nonimmune rabbit serum reduced the apoptotic event induced by serum deprivation, whereas neutralization of endogenous ET-1 by polyclonal anti–ET-1 antiserum abrogated this protective effect. The ET B receptor antagonist (BQ788; 10 −8 to 10 −6 mol/L), but not the ET A receptor antagonist (BQ123; 10 −8 to 10 −6 mol/L), significantly inhibited proliferation of endothelial cells. These data suggest that ET-1, as well as mitogen, functions as an apoptosis survival factor for endothelial cells in an autocrine/paracrine manner via the ET B receptor.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Cited by 154 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3